Will Mesenchymal Stem Cells Be Future Directions for Treating Radiation-induced Skin Injury?
Overview
Authors
Affiliations
Radiation-induced skin injury (RISI) is one of the common serious side effects of radiotherapy (RT) for patients with malignant tumors. Mesenchymal stem cells (MSCs) are applied to RISI repair in some clinical cases series except some traditional options. Though direct replacement of damaged cells may be achieved through differentiation capacity of MSCs, more recent data indicate that various cytokines and chemokines secreted by MSCs are involved in synergetic therapy of RISI by anti-inflammatory, immunomodulation, antioxidant, revascularization, and anti-apoptotic activity. In this paper, we not only discussed different sources of MSCs on the treatment of RISI both in preclinical studies and clinical trials, but also summarized the applications and mechanisms of MSCs in other related regenerative fields.
Shestakova V, Smirnova E, Atiakshin D, Kisel A, Koryakin S, Litun E Int J Mol Sci. 2025; 26(5).
PMID: 40076619 PMC: 11900442. DOI: 10.3390/ijms26051994.
Miura Y, Fujii S, Ichinohe T J Radiat Res. 2024; 65(Supplement_1):i80-i87.
PMID: 39679884 PMC: 11647929. DOI: 10.1093/jrr/rrae009.
A critical review of the progress in prevention and treatment of radiation-induced skin damage.
Kemin L, Rutie Y Front Oncol. 2024; 14:1395778.
PMID: 39664182 PMC: 11631922. DOI: 10.3389/fonc.2024.1395778.
Zhang Y, Wang C, Li J Exp Hematol Oncol. 2024; 13(1):64.
PMID: 38951845 PMC: 11218091. DOI: 10.1186/s40164-024-00532-4.
Zhang X, Shi W, Wang X, Zou Y, Xiang W, Lu N Curr Stem Cell Res Ther. 2023; 19(8):1142-1152.
PMID: 37694794 DOI: 10.2174/1574888X19666230908142426.